Guidelines for sexually transmitted infections (STI) and preventive health highlight the importance of testing sexually active people from high risk populations. [3] [4] [5] Aboriginal and Torres Strait Islander peoples (the term Aboriginal is used throughout this study to refer to both the Aboriginal and the Torres Strait Islander populations) are disproportionately affected by genital chlamydia infection 6, 7 and its sequelae. 8, 9 Aboriginal Community Controlled Health Services (ACCHSs) provide culturally appropriate primary healthcare to Aboriginal Australians, including opportunistic testing for chlamydia. While large remote area ACCHSs with comprehensive sexual health programs have reduced STI incidence through high testing coverage and screening, 10, 11 and 73% of ACCHSs offer STI screening, 12 the extent of chlamydia testing and diagnoses among patients attending ACCHSs is unclear.
This paper reports on opportunistic chlamydia testing and positivity rates among 16- Annual chlamydia testing rates (proportion of patients tested for chlamydia) and chlamydia positivity rates (proportion of those tested found to be infected) were calculated. Repeat testing was assessed as the proportion of individuals tested during 2008 who were retested in 2009.
Repeat attendances and tests within the same year were excluded from annual testing and positivity rates, as were tests without results. Data for one ACCHS lacked results for more than 15% of tests and were excluded from positivity estimates. Data for two ACCHSs with Aboriginal status unknown for more than 15% of patients were excluded from description of Aboriginality. Rates were compared using two-sample tests of proportions and chi-square test for trend, with a significance level of 0.05, in STATA version 10.
Formal approval for ACCHSs to participate in ACCESS was gained from each ACCHS governing board. Ethical approval was gained from the appropriate Human Research Ethics Committees (HREC) in each state with the Alfred Hospital, Victoria, being the primary HREC site. Table 2 . Over both years, positivity was highest among 16-19 year olds (females: 17.4%; males: 13.0%) and declined to 1.5% among 35-39 year old females (p<0.001) and to 4.8% among 30-34 year old males (p<0.001). 
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This is the first study that provides chlamydia testing and positivity rates in a large sample of patients attending metropolitan, regional and remote ACCHSs across Australia. Previous reports focused on STI screening in remote communities 10, 11, 17 or other settings such as private fee for service general practices (GPs). 18 Importantly, our analysis found that a fifth of 16-29 year old female attendees were tested annually for chlamydia as part of routine practice and more than a third of females aged 16-39 years tested in 2008 were retested in 2009. Other findings include lower testing rates among males and older patients.
The testing rates for 16-29 year old females (19.5%) and males (11.4%) were significantly higher than age equivalent rates among females (7.4%) and males (4.3%) observed in private GPs in ACCESS. 6 While close to the 20-30% annual testing coverage among those <25 or <30 years that mathematical modelling suggests could halve chlamydia prevalence in Australia over 10 years 19 -particularly for females -it is important to recognise that the models were based on data largely relating to the general Australian population, among whom chlamydia prevalence, [20] [21] [22] risk behaviours 23 and access to primary healthcare 24 are likely to be different to Aboriginal subpopulations. It is unclear what optimal testing coverage should be in subpopulations with higher infection rates but they may need to be higher than required for the general population.
The value of high testing coverage accompanied by high treatment rates via comprehensive sexual health programs has been demonstrated in remote Australian Aboriginal communities. One program in the Anangu Pitjantjatjara Yankunytjatjara lands of South Australia targeted high STI prevalence among 14-40 year olds via an annual population-wide screen and year-round opportunistic testing. 10 Another program in the Tiwi Islands focused on opportunistic testing among 15-35 year olds to target chlamydia and gonorrhoea prevalence of around 5-6%. 11 Testing coverage of 61-78% from 1996-2008 10 and 82-84% from 2002-2005 11 was followed by reduced chlamydia and gonorrhoea prevalence in both regions.
Some guidelines and studies suggest population-wide screening is needed in addition to opportunistic screening to have an impact on high STI prevalence. 3, 10 However, integration of opportunistic testing into existing programs in comprehensive Aboriginal primary healthcare 3, 25 is more feasible and sustainable than population-wide testing. Chlamydia testing in this study was largely opportunistic and at some ACCHSs was complemented by health promotion and community education targeting high-risk groups and encouraging attendance for general and sexual health needs. Higher testing and retesting rates observed in females may reflect factors influencing opportunistic testing such as guidelines recommending STI testing during antenatal visits, 3, 5 with cervical screening during a women's health check 5 or when obtaining contraception. 3 STI testing for men and women may be a priority in high-prevalence communities and may also be influenced by community awareness of the risks for STIs and simplicity of chlamydia testing and treatment. 3, 5 Higher testing rates in 2009 than for 2008 suggest increased testing, although a longer period is needed to determine reliable time trends.
Chlamydia positivity was highest among 16-19 year olds and declined with age, consistent with notification data. 6, 7 Reinfection is common among young people diagnosed with chlamydia [26] [27] [28] and repeat testing of all infected individuals three 2,5 to twelve 4 months post treatment to check for reinfection is recommended. Of patients in this study found positive in 2008, two-fifths of females and onefifth of males were retested in 2009. It is not possible to ascertain if the remaining patients were offered testing but declined, were tested at other services, or were unable to be contacted. Low retesting is of concern because of the risk of reinfection [26] [27] [28] but is common in private general practices. 29 In part, low retesting following infection may reflect a lack of clear guidelines for when retesting should occur.
Participating ACCHSs received ACCESS results through a workshop chaired by NACCHO and a report detailing aggregated and service-level testing and positivity rates. Sites reported improved understanding of local testing practices which may foster local continuous quality improvement activity for opportunistic testing and sexual health programs.
A limitation of this analysis is that the pilot ACCHS network comprised few sites, reducing representativeness and the potential for analyses by jurisdiction or location. A second limitation is that the ACCESS system does not collect data on the total population in the catchment areas, precluding determination of attendance or population testing rates. Another limitation relates to completeness of test result and Aboriginal status data. Missing test results may bias positivity estimates. US Centers for Disease Control and Prevention surveillance standards regard ≥85% surveillance data as complete. 30 Accordingly, in this analysis, data from one ACCHS with >15% test results missing were excluded from positivity estimates.
The ACCESS project successfully established a network for measuring chlamydia testing and positivity rates at ACCHSs throughout Australia. It provided new information on opportunistic testing levels and has assisted individual ACCHSs to use their data for local quality improvement and health promotion. This study found higher chlamydia testing rates within ACCHSs than in private GPs in ACCESS. At the same, time there is scope to increase opportunistic testing among clinic attendees. ACCHSs are well placed to provide enhanced sexual health services, particularly if they are appropriately resourced to do this in the context of the many competing health priorities they face. High chlamydia positivity among younger people highlights the importance of focusing on regular chlamydia testing in conjunction with appropriate clinical care and prevention services.
